IPO registrations (S-1, F-1) · Registrants
NEOGENOMICS INC
- SEC CIK
- 1077183 · filings on EDGAR ↗
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC (1999–2002)
- Registration
- Form S-1, first filed 2008-06-03, last 2012-11-05; 3 initial registrations, 3 amendments
- Outcome
- Declared effective 2008-07-01; withdrawal requested 2012-11-26
- Industry (SIC)
- Services-Testing Laboratories 8734
- Incorporated in
- NV
- Business address
- 9490 NEOGENOMICS WAY, Fort Myers, FL 33912
- EIN
- 74-2897368
- Ticker
- NEO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- NEOGENOMICS INC on the corporate pages
Offering terms
- Shares offered
- 3,000,000
- Listing
- OTCQB under the symbol NGNM
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: AMERICAN COMMUNICATIONS ENTERPRISES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: NEOGENOMICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- SEC filer: NEOGENOMICS INC EXACT (CIK (EXACT))
- Person page: Bruce K Crowther Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Steven G Brodie Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 22
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-06-03 | S-1/A | S-1/A (amendment) | NEOGENOMICS INC | 0001077183-08-000016 ↗ |
| 2008-06-03 | S-1/A | S-1/A (amendment) | NEOGENOMICS INC | 0001077183-08-000018 ↗ |
| 2008-07-01 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-08-002080 ↗ |
| 2008-11-28 | S-1 | S-1 (registration) | NEOGENOMICS INC | 0001144204-08-067111 ↗ |
| 2009-01-22 | S-1/A | S-1/A (amendment) | NEOGENOMICS INC | 0001144204-09-002958 ↗ |
| 2009-02-05 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-09-000302 ↗ |
| 2009-05-08 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-09-001344 ↗ |
| 2010-05-05 | S-1 | S-1 (registration) | NEOGENOMICS INC | 0001144204-10-024421 ↗ |
| 2010-05-13 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-10-001493 ↗ |
| 2010-05-19 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-10-001552 ↗ |
| 2011-04-13 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-11-000995 ↗ |
| 2011-04-13 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-11-000997 ↗ |
| 2012-05-11 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-12-001517 ↗ |
| 2012-05-11 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-12-001519 ↗ |
| 2012-11-05 | S-1 | S-1 (registration) | NEOGENOMICS INC | 0001193125-12-452164 ↗ |
| 2012-11-26 | RW | RW (withdrawal request) | NEOGENOMICS INC | 0001193125-12-480724 ↗ |
| 2013-02-12 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-13-000466 ↗ |
| 2013-05-10 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-13-001473 ↗ |
| 2013-05-10 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-13-001474 ↗ |
| 2014-01-03 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-14-000037 ↗ |
| 2014-05-07 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-14-001352 ↗ |
| 2014-05-07 | EFFECT | EFFECT (declared effective) | NEOGENOMICS INC | 9999999995-14-001353 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-11-05 | S-1 | registration statement | $1.50 | 3,000,000 | $4,500,000 | OTCQB NGNM | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ASPEN SELECT HEALTHCARE LP | Director,Officer; Director,Officer,TenPercentOwner; Officer; TenPercentOwner | Executive VP of Finance | 9 | 2011–2015 | |
| CARDOZA GEORGE | Officer | CFO; Chief Financial Officer; President & COO, Lab Ops; President, Pharma Services | 25 | 2011–2022 | |
| DENT MICHAEL T | Director | 11 | 2011–2014 | ||
| DVONCH JEROME J | Officer | Prinicpal Accounting Officer | 1 | 2011 | |
| GASPARINI ROBERT P | Director,Officer; Officer | Chief Science Officer; Chief Scientific Officer | 13 | 2011–2014 | |
| HIPP RAYMOND R | Director | 15 | 2011–2020 | ||
| JONES STEVEN C | Director; Director,Officer; Director,Officer,TenPercentOwner; Officer | Executive Vice President; Executive VP of Finance | 38 | 2011–2021 | |
| MILLER MARYDAWN | Officer | Vice President of IT | 1 | 2011 | |
| PETERSON PETER M | Director; Director,TenPercentOwner | 2 | 2011–2012 | ||
| Robison William J | Director | 9 | 2011–2017 | ||
| SMITS MARK W | Officer | Chief Commercial Officer | 2 | 2011 | |
| VAN OORT DOUGLAS M | Director; Director,Officer; Officer | Chairman and CEO | 37 | 2011–2021 | |
| Johnson Kevin C | Director | 20 | 2011–2021 | ||
| CLEARMAN STEPHEN J | Other; TenPercentOwner | 4 | 2012–2013 | ||
| KINDERHOOK CAPITAL MANAGEMENT, LLC | Other; TenPercentOwner | 4 | 2012–2013 | ||
| KINDERHOOK GP LLC | Other; TenPercentOwner | 4 | 2012–2013 | ||
| KINDERHOOK, LP | Other; TenPercentOwner | 4 | 2012–2013 | ||
| Shah Tushar | Other; TenPercentOwner | 4 | 2012–2013 | ||
| ROSS STEVEN A | Officer | CIO | 9 | 2013–2018 | |
| ALBITAR MAHER | Officer | Chief Medical Officer | 10 | 2013–2017 | |
| SHOVLIN ROBERT J. | Officer | Chief Growth Officer; Chief Operating Officer; President, Clinical Services | 21 | 2014–2021 | |
| CROWTHER BRUCE K | Director | 17 | 2014–2023 | person page Fuzzy | |
| HOREL ROBERT H. | Officer | Vice President andGM PathLogic; Vice President GM PathLogic | 4 | 2014–2015 | |
| BALLIET JENNIFER | Officer | Vice President Human Resources; Vice President of HR; VP and Chief Culture Officer; VP of Human Resources | 25 | 2015–2021 | |
| BRODIE STEVEN G. | Officer | Chief Scientific Officer; President, Pharma Services; Vice President of Operations; VP - Pharma Operations | 12 | 2015–2018 | person page Fuzzy |
| HANNAH ALISON L. | Director | 20 | 2015–2025 | ||
| TETRAULT LYNN A. | Director | 27 | 2015–2026 | ||
| GE Medical Systems Information Technologies, Inc. | Other; TenPercentOwner | 6 | 2016–2018 | ||
| GENERAL ELECTRIC CO | Other; TenPercentOwner | 6 | 2016–2018 | ||
| Machulcz Mark Alan | Officer | Vice President of Operations | 2 | 2016 | |
| Murphy Kieran Pius | Director | 1 | 2016 | ||
| KANOVSKY STEPHEN M | Director | 11 | 2017–2026 | ||
| McKenzie Kathryn B | Officer | Chief Accounting Officer; Chief Financial Officer; Chief Sustainability/Risk Ofcr; Principal Accounting Officer | 11 | 2017–2022 | |
| Virag Sharon | Officer | Chief Financial Officer | 3 | 2018–2019 | |
| Bonello William | Officer | Chief Financial Officer; Chief Strategy Officer; President, Informatics; VP, Investor Relations | 16 | 2018–2022 | |
| BYWATER STEPHANIE K | Officer | Chief Compliance Officer | 1 | 2018 | |
| Weiss Lawrence Martin | Officer | Chief Medical Officer; Chief Scientific Officer | 7 | 2018–2021 | |
| Pedulla Denise E | Officer | General Counsel | 4 | 2020–2021 | |
| Stahler Rachel A | Director | 4 | 2020–2022 | ||
| Dieter Cynthia J | Officer | Chief Accounting Officer | 10 | 2020–2023 | |
| Kelly Michael Aaron | Director | 10 | 2020–2026 | ||
| Brown Douglas Matthew | Officer | Chief Strategy Officer | 6 | 2021–2022 | |
| Mallon Mark | Director,Officer | Chief Executive Officer | 5 | 2021–2022 | |
| Morris Clive | Officer | President of Inivata | 3 | 2021 | |
| Wallar Gina M | Officer | President, Pharma Services | 5 | 2021–2022 | |
| Gilbert Halley E | Officer | Chief Legal Officer | 5 | 2021–2022 | |
| Daly David | Director | 3 | 2021–2022 | ||
| Sholehvar David | Officer | President, Clinical Services | 3 | 2022 | |
| Sikri Vishal | Officer | President Advanced Diagnostics; President and CCO, Inivata; President, Pharma Services | 6 | 2022–2024 | |
| Kulkarni Shashikant | Officer | Chief Scientific Officer; President of Lab Operations | 4 | 2022–2023 | |
| Smith Christopher M | Officer | Chief Executive Officer | 8 | 2022–2025 | |
| Olivo Alicia C | Officer | EVP, GC & Business Development; General Counsel | 31 | 2022–2026 | |
| Perez David Brian | Director | 8 | 2022–2026 | ||
| Stone Warren | Officer | Chief Commerical Officer; Pres & Chief Operating Officer; President, Clinical Services | 22 | 2022–2026 | |
| Sherman Jeffrey Scott | Officer | Chief Financial Officer | 15 | 2022–2026 | |
| Harris Melody | Officer | Chf Ops Off, Pres, Informatics; President, Enterprise Ops | 10 | 2022–2025 | |
| Aunan Greg D | Officer | Chief Accounting Officer | 8 | 2023–2026 | |
| Floegel Elizabeth | Director | 5 | 2023–2025 | ||
| Zook Anthony P. | Director; Director,Officer | Chief Executive Officer | 10 | 2023–2026 | |
| Gunn Neil | Director | 7 | 2023–2026 | ||
| Williams Felicia | Director | 4 | 2024–2026 | ||
| Green Marjorie C | Director | 3 | 2025–2026 | ||
| Kenny John P. | Director | 3 | 2026 | ||
| Jain Abhishek | Officer | Chief Financial Officer | 1 | 2026 | |
| Starrett Carolyn S | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | NEOGENOMICS, INC. | FL | State business registries | name and state |
| SEC filer | NEOGENOMICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | NeoGenomics, Inc. | FL | Trademarks (USPTO) | name and state |
| Business registration | AMERICAN COMMUNICATIONS ENTERPRISES, INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Person page | Bruce K Crowther | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Steven G Brodie | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Testing Laboratories, FL first:
- Medytox Solutions, Inc. FL
- GREENSCAPE LABORATORIES, INC. FL
- UL Solutions Inc. IL
- 20/20 Biolabs, Inc. MD
- AAIPHARMA INC NC
- ORCHID CELLMARK INC NJ
- ERESEARCHTECHNOLOGY INC /DE/ PA
In other datasets, the same topic (Science) in FL:
- Nonprofit: ACADEMY OF MARINE SCIENCES INC (Nonprofits (IRS Form 990))
Interests: Services-Testing Laboratories · Science